FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1981750503> ?p ?o ?g. }

• W1981750503 endingPage "S233" @default.
• W1981750503 startingPage "S232" @default.
• W1981750503 abstract "BackgroundVon Willebrand Factor (VWF) gene expression is restricted to endothelial cells and is commonly used as a marker to distinguish endothelial cells from other cell type. However, consistent with heterogeneity of endothelial cells, VWF is not uniformly expressed by endothelial cells of all vascular beds. In lung, while VWF expression is highly abundant and uniformly expressed in vessels of diameters 40 um or above, expression in capillaries and microvessels is low and displays a mosaic pattern. Increased VWF levels in lung is associated with diseases such as pulmonary hypertension (PH), contributing to the thrombogenicity, and increased mortality. However, the mechanism leading to increased VWF levels in PH has not been determined, and is the aim of our present studies. Analyses of the mechanism of endothelial-specific regulation of VWF gene in vivo has demonstrated that VWF gene contains regions that dictate its activation only in subpopulations of endothelial cells. We previously described a distinct region of the VWF promoter (sequences −487 to +247) that targets expression in vivo only to brain endothelium. We have also demonstrated that another specific regulatory region in intron 51 targets activation in lung endothelium.MethodsOur characterization of the region that targets the VWF promoter activity to lung endothelial cells and generation of transgenic mice that express LacZ gene under the regulation of these VWF regulatory sequences (HSS-VWF-LacZ and VWF-LacZ-HSS) provided the opportunity to explore whether pulmonary hypertension results in modulation of the VWF promoter activity in lung endothelial cells.ResultsOur analyses demonstrated that PH induced by hypoxia exposure results in upregulation of the exogenous VWF promoter activity in brain and lung (demonstrated by RNA and protein analyses of the LacZ transgene), and specifically activates expression in lung microvascular endothelial cells (demonstrated by immunoflourescence and confocal microscopy). This pattern of exogenous VWF promoter activity was concomitant with increased expression of endogenous VWF and a change in its expression pattern from primarily larger vessels endothelium to include those of microvasculature. Additionally promoter activation in hypoxic mice was detected in heart endothelial cells that in control mice do not support the activity of the VWF promoter-HSS (intron 51) sequences.ConclusionThese results suggests that hypoxia/PH leads to a phenotypic switch of microvascular endothelial cells from an anti-coagulant to a procoagulant activity, which is potentially regulated by changes in the activity of transacting factors that participate in regulation of VWF gene expression.Canadian Institutes of Health Research (CIHR) BackgroundVon Willebrand Factor (VWF) gene expression is restricted to endothelial cells and is commonly used as a marker to distinguish endothelial cells from other cell type. However, consistent with heterogeneity of endothelial cells, VWF is not uniformly expressed by endothelial cells of all vascular beds. In lung, while VWF expression is highly abundant and uniformly expressed in vessels of diameters 40 um or above, expression in capillaries and microvessels is low and displays a mosaic pattern. Increased VWF levels in lung is associated with diseases such as pulmonary hypertension (PH), contributing to the thrombogenicity, and increased mortality. However, the mechanism leading to increased VWF levels in PH has not been determined, and is the aim of our present studies. Analyses of the mechanism of endothelial-specific regulation of VWF gene in vivo has demonstrated that VWF gene contains regions that dictate its activation only in subpopulations of endothelial cells. We previously described a distinct region of the VWF promoter (sequences −487 to +247) that targets expression in vivo only to brain endothelium. We have also demonstrated that another specific regulatory region in intron 51 targets activation in lung endothelium. Von Willebrand Factor (VWF) gene expression is restricted to endothelial cells and is commonly used as a marker to distinguish endothelial cells from other cell type. However, consistent with heterogeneity of endothelial cells, VWF is not uniformly expressed by endothelial cells of all vascular beds. In lung, while VWF expression is highly abundant and uniformly expressed in vessels of diameters 40 um or above, expression in capillaries and microvessels is low and displays a mosaic pattern. Increased VWF levels in lung is associated with diseases such as pulmonary hypertension (PH), contributing to the thrombogenicity, and increased mortality. However, the mechanism leading to increased VWF levels in PH has not been determined, and is the aim of our present studies. Analyses of the mechanism of endothelial-specific regulation of VWF gene in vivo has demonstrated that VWF gene contains regions that dictate its activation only in subpopulations of endothelial cells. We previously described a distinct region of the VWF promoter (sequences −487 to +247) that targets expression in vivo only to brain endothelium. We have also demonstrated that another specific regulatory region in intron 51 targets activation in lung endothelium. MethodsOur characterization of the region that targets the VWF promoter activity to lung endothelial cells and generation of transgenic mice that express LacZ gene under the regulation of these VWF regulatory sequences (HSS-VWF-LacZ and VWF-LacZ-HSS) provided the opportunity to explore whether pulmonary hypertension results in modulation of the VWF promoter activity in lung endothelial cells. Our characterization of the region that targets the VWF promoter activity to lung endothelial cells and generation of transgenic mice that express LacZ gene under the regulation of these VWF regulatory sequences (HSS-VWF-LacZ and VWF-LacZ-HSS) provided the opportunity to explore whether pulmonary hypertension results in modulation of the VWF promoter activity in lung endothelial cells. ResultsOur analyses demonstrated that PH induced by hypoxia exposure results in upregulation of the exogenous VWF promoter activity in brain and lung (demonstrated by RNA and protein analyses of the LacZ transgene), and specifically activates expression in lung microvascular endothelial cells (demonstrated by immunoflourescence and confocal microscopy). This pattern of exogenous VWF promoter activity was concomitant with increased expression of endogenous VWF and a change in its expression pattern from primarily larger vessels endothelium to include those of microvasculature. Additionally promoter activation in hypoxic mice was detected in heart endothelial cells that in control mice do not support the activity of the VWF promoter-HSS (intron 51) sequences. Our analyses demonstrated that PH induced by hypoxia exposure results in upregulation of the exogenous VWF promoter activity in brain and lung (demonstrated by RNA and protein analyses of the LacZ transgene), and specifically activates expression in lung microvascular endothelial cells (demonstrated by immunoflourescence and confocal microscopy). This pattern of exogenous VWF promoter activity was concomitant with increased expression of endogenous VWF and a change in its expression pattern from primarily larger vessels endothelium to include those of microvasculature. Additionally promoter activation in hypoxic mice was detected in heart endothelial cells that in control mice do not support the activity of the VWF promoter-HSS (intron 51) sequences. ConclusionThese results suggests that hypoxia/PH leads to a phenotypic switch of microvascular endothelial cells from an anti-coagulant to a procoagulant activity, which is potentially regulated by changes in the activity of transacting factors that participate in regulation of VWF gene expression.Canadian Institutes of Health Research (CIHR) These results suggests that hypoxia/PH leads to a phenotypic switch of microvascular endothelial cells from an anti-coagulant to a procoagulant activity, which is potentially regulated by changes in the activity of transacting factors that participate in regulation of VWF gene expression." @default.
• W1981750503 created "2016-06-24" @default.
• W1981750503 creator A5021152638 @default.
• W1981750503 creator A5036258568 @default.
• W1981750503 creator A5038543810 @default.
• W1981750503 creator A5070411706 @default.
• W1981750503 date "2011-09-01" @default.
• W1981750503 modified "2023-10-16" @default.
• W1981750503 title "470 Hypoxia-induced pulmonary hypertension in mice modifies the expression pattern of von willebrand factor gene in lung endothelial cells" @default.
• W1981750503 doi "https://doi.org/10.1016/j.cjca.2011.07.393" @default.
• W1981750503 hasPublicationYear "2011" @default.
• W1981750503 type Work @default.
• W1981750503 sameAs 1981750503 @default.
• W1981750503 citedByCount "0" @default.
• W1981750503 crossrefType "journal-article" @default.
• W1981750503 hasAuthorship W1981750503A5021152638 @default.
• W1981750503 hasAuthorship W1981750503A5036258568 @default.
• W1981750503 hasAuthorship W1981750503A5038543810 @default.
• W1981750503 hasAuthorship W1981750503A5070411706 @default.
• W1981750503 hasConcept C126322002 @default.
• W1981750503 hasConcept C164705383 @default.
• W1981750503 hasConcept C178790620 @default.
• W1981750503 hasConcept C185592680 @default.
• W1981750503 hasConcept C2777714996 @default.
• W1981750503 hasConcept C2779394231 @default.
• W1981750503 hasConcept C2780930700 @default.
• W1981750503 hasConcept C540031477 @default.
• W1981750503 hasConcept C71924100 @default.
• W1981750503 hasConcept C7836513 @default.
• W1981750503 hasConcept C89560881 @default.
• W1981750503 hasConceptScore W1981750503C126322002 @default.
• W1981750503 hasConceptScore W1981750503C164705383 @default.
• W1981750503 hasConceptScore W1981750503C178790620 @default.
• W1981750503 hasConceptScore W1981750503C185592680 @default.
• W1981750503 hasConceptScore W1981750503C2777714996 @default.
• W1981750503 hasConceptScore W1981750503C2779394231 @default.
• W1981750503 hasConceptScore W1981750503C2780930700 @default.
• W1981750503 hasConceptScore W1981750503C540031477 @default.
• W1981750503 hasConceptScore W1981750503C71924100 @default.
• W1981750503 hasConceptScore W1981750503C7836513 @default.
• W1981750503 hasConceptScore W1981750503C89560881 @default.
• W1981750503 hasIssue "5" @default.
• W1981750503 hasLocation W19817505031 @default.
• W1981750503 hasOpenAccess W1981750503 @default.
• W1981750503 hasPrimaryLocation W19817505031 @default.
• W1981750503 hasRelatedWork W1002741611 @default.
• W1981750503 hasRelatedWork W2029139678 @default.
• W1981750503 hasRelatedWork W2096807231 @default.
• W1981750503 hasRelatedWork W2114866235 @default.
• W1981750503 hasRelatedWork W2360437166 @default.
• W1981750503 hasRelatedWork W2374601116 @default.
• W1981750503 hasRelatedWork W2387125662 @default.
• W1981750503 hasRelatedWork W2395598249 @default.
• W1981750503 hasRelatedWork W2401101176 @default.
• W1981750503 hasRelatedWork W2410147433 @default.
• W1981750503 hasVolume "27" @default.
• W1981750503 isParatext "false" @default.
• W1981750503 isRetracted "false" @default.
• W1981750503 magId "1981750503" @default.
• W1981750503 workType "article" @default.